Dabur India Q3 FY26 Update: Mid-Single Digit Revenue Growth Expected
Dabur India expects Q3 FY26 consolidated revenue to grow in the mid-single digits, with operating profit and PAT growing ahead of revenue. Home & Personal care is projected for double-digit growth, while Healthcare expects low-single-digit growth. International business anticipated near double-digit growth. Demand recovery is noted.
The update provides a preliminary outlook on Q3 FY26 performance, indicating expected growth across various business segments and overall revenue. This information is material for investors assessing the company's short-term financial health.
The company's update indicates positive demand trends, sequential improvement in key segments like Healthcare, and expected growth in revenue and profits, signaling a positive outlook.
Dabur India Limited has provided a quarterly update for the period ended December 31, 2025 (Q3 FY26), indicating early signs of demand recovery driven by GST rate revisions. Following initial inventory adjustments by distributors and retailers in October 2025, consumer sentiment improved, with rural demand continuing to outperform urban demand.
The company anticipates double-digit growth in its Home & Personal Care business, led by strong performance in Hair Oils and Oral Care categories, with key brands like Dabur Amla franchise, Dabur Almond, Dabur Anmol, Dabur Red Toothpaste, and Meswak expected to show healthy volume-led growth. Most of the portfolio is projected to gain market share.
The Healthcare segment is expected to see sequential improvement, with Dabur Honey projected to grow around 10%, and Honitus and Health Juices seeing over 15% year-on-year growth. The Hajmola franchise and Ethical portfolio are likely to post mid-single-digit growth. While Dabur Chyawanprash's primary sales growth may be muted, secondary sales remain positive, and momentum is expected to build in January 2026 due to an extended winter. Overall, the Healthcare business is expected to report low-single-digit growth.
In the Foods & Beverages (F&B) segment, the Culinary business is anticipated to achieve double-digit growth. The Beverages portfolio, particularly the premium 'Real Activ' range, is expected to perform well, with 100% Activ juices and Coconut water projected to grow by over 30% each. The beverage portfolio has gained market share.
Organized trade, including E-commerce and Quick Commerce, is expected to maintain strong growth momentum. The International business is projected to post near double-digit growth in INR terms, with strong performance noted in MENA, Turkey, Namaste, and Bangladesh.
Overall, Dabur India expects consolidated revenue to grow in the mid-single digits, with operating profit and Profit After Tax growing ahead of revenue. Favorable macroeconomic conditions and recent tax reforms are anticipated to support sustained demand recovery in the coming quarters. The company will release detailed financial results after Board approval.
What to do with a filing like this
Dabur India Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Dabur India Limited. Read the original for the full detail.